CAPS is caused by gain‐of‐function mutations in the NLRP3 gene, resulting in aberrant activation of the NLRP3 inflammasome and subsequent overproduction of interleukin (IL)‐1β. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.